The data shows that variants predicted to affect microexons are predominant in the 85% of autistic individuals that lack a genetic link.

The list of tools includes SpliceA12, a new iteration of a genomic AI model designed to identify disease-relevant splice ...

A small-molecule therapy, VG-3927, targeting microglial TREM2 signaling showed neuroprotective effects in preclinical studies ...

New immune profiling tool could lead to new ways of screening for preterm birth risk, or new preventive interventions.

Research shows that as biocatalysts, solvents can affect stereochemistry, thermostability, and other process parameters.

Strategic automation and flexible bioprocessing could help cell and gene therapies scale across diverse APAC markets.

Results provide framework for uncovering regulatory variants in other X chromosome neurodevelopmental genes that may ...

Under the terms of the pharma deal, Enodia will screen, optimize, and develop Sec61 inhibitor candidates against multiple ...

Light‑controlled gene expression using optogenetics is emerging as a credible alternative to traditional cell line development.

UCB has dedicated the Rowen, GA, site where it plans to build a $2 billion biologics manufacturing campus that is set to open ...

Caribou Biosciences (Nasdaq: CRBU), whose co-founders include Jennifer Doudna, PhD, capped a one-year 83% freefall of its stock after announcing plans to evaluate strategic alternatives, as investors ...

Sickle cell trait is associated with distinct malaria parasite genotypes, potentially explaining reduced disease risk despite ...